Anacor Pharmaceuticals, Inc. company info

CIK 1411158
IRS Number 251854385
State of incorporation DE
Business address 1020 E. MEADOW CIRCLE
Mail address 1020 E. MEADOW CIRCLE

Short summary

Anacor Pharmaceuticals, Inc. is a California company, with head office located at 1020 E. Meadow Circle Palo Alto, California 94303. In 2015 the company owned a total of 164.00 million USD worth of assets, including 157.30 million USD worth of current assets. 2014 was the year when the company amassed the most assets. The company net sales last year amounted to 82.36 million USD, which means a 298.12% increase when compared to 2014. The company allocated 73.86 million USD of its income to research and development.

Anacor Pharmaceuticals, Inc. Income Statement

Name [in Millions USD]20082009201020112012201320142015Trends
Revenue, Net 27.8220.3110.7417.2320.6982.36
Selling, General and Administrative Expense 11.6120.6531.3960.85
Research and development 34.0829.8756.1052.3246.5672.4973.86
Operating Expenses 41.1437.3266.6563.93-75.29111.48138.73
Operating Income (Loss) -22.49-9.49-46.34-53.1992.52-90.80-56.38
Interest expense 2.432.011.402.914.054.715.54
Other Nonoperating Income (Expense) -0.081.42-0.04-0.05-0.67-0.19
Income Tax Expense (Benefit) -0.021.71-10.26

Anacor Pharmaceuticals, Inc. Balance Sheet

Name [in Millions USD]20082009201020112012201320142015Trends
Cash and cash equivalents 47.315.0911.004.957.3219.967.4924.97
Available-for-sale Securities, Current 52.2136.0238.51106.45159.86110.65
Inventories 3.182.68
Property, Plant and Equipment, Gross 5.836.276.727.408.68
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 4.094.765.265.766.38
Available-for-sale Securities, Noncurrent 0.227.371.20
Other Assets, Noncurrent 0.600.030.541.892.852.29
Total assets 68.4646.3556.97137.63195.78164.00
Current assets 65.8444.5051.54131.33181.81157.30
Accounts payable 2.903.554.805.224.513.67
Total current liabilities 19.0621.7515.4622.8429.1625.01
Deferred Revenue, Noncurrent 9.755.215.400.1534.0131.67
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit) -140.17-188.29-244.39-176.13-243.75-294.99
Accumulated Other Comprehensive Income (Loss), Net of Tax 0.01-0.01-0.010.04-0.010.17

Anacor Pharmaceuticals, Inc. Cash Flow

Name [in Millions USD]20082009201020112012201320142015Trends
Depreciation and amortization 0.750.730.650.670.510.500.63
Deferred Income Tax Expense (Benefit) -10.26
Inventories 2.410.41
Accounts payable -0.310.390.880.001.69-0.190.76
Deferred revenue -10.682.150.37-2.99-5.6538.94-3.66
Payments to Acquire Property, Plant, and Equipment
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -6.44-51.1519.43-0.58-17.46-125.6583.02
Proceeds from Issuance of Common Stock 42.5222.61